LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 21

Search options

  1. Article ; Online: Potential medical impact of unrecognized

    Wu, Alan H B / Peacock, W Franklin

    Clinical chemistry and laboratory medicine

    2024  

    Abstract: Objectives: The destruction of red cells during blood collection or with the processing of the sample continues to occur at a high rate, especially among emergency department (ED) patients. This can produce pre-analytical laboratory errors, particularly ...

    Abstract Objectives: The destruction of red cells during blood collection or with the processing of the sample continues to occur at a high rate, especially among emergency department (ED) patients. This can produce pre-analytical laboratory errors, particularly for potassium. We determined the incidence of hemolyzed samples and discuss the potential medical impact for hypokalemic patients who potassium level is artificially normal (pseudoeukalemia).
    Methods: Potassium results were obtained for a 6-month period. Using a measured hemolysis index (HI), hemolysis was present in 3.1 % for all potassium ordered (n=94,783) and 7.5 % for ED orders (n=22,770). Most of these samples were reported as having high normal result or were hyperkalemic. There were 22 hemolytic samples with a potassium of <3.5 mmol/L, and 57 hemolytic samples with a potassium in lower limit of normal (3.5-3.8 mmol/L). From this group, we examined the medical histories of 8 selected patients whose initially normal potassium levels were subsequently confirmed to have a potassium values that were below, at, or just above the lower limit of normal due to hemolysis.
    Results: The primary complaint for these patients were: necrotizing soft tissue infection, pancreatitis, volume overload from heart failure with reduced ejection fraction, hypertension treated with hydrochlorothiazide, and presence of a short bowel syndrome. A subsequent non-hemolyzed sample was collected demonstrating hypokalemia in all of these patients. Within these cases, there was a potential for harm had hemolysis detection not been performed.
    Conclusions: We demonstrate the medical importance of detecting hemolysis for patients who have pseudoeukalemia. This is relevant because the HI cannot be obtained when electrolytes are tested using whole blood samples, and a normal potassium may lead to inappropriate patient management.
    Language English
    Publishing date 2024-04-15
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1418007-8
    ISSN 1437-4331 ; 1434-6621 ; 1437-8523
    ISSN (online) 1437-4331
    ISSN 1434-6621 ; 1437-8523
    DOI 10.1515/cclm-2024-0351
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Will SCUBE1 solve the ischemia marker deficit?

    Peacock, W Franklin

    Journal of the American College of Cardiology

    2008  Volume 51, Issue 22, Page(s) 2181–2183

    MeSH term(s) Acute Coronary Syndrome/blood ; Acute Coronary Syndrome/physiopathology ; Biomarkers/blood ; Brain Ischemia/complications ; Brain Ischemia/etiology ; Humans ; Membrane Proteins/blood ; Platelet Activation ; Prognosis ; Stroke/blood ; Stroke/etiology ; Stroke/physiopathology
    Chemical Substances Biomarkers ; Membrane Proteins ; SCUBE1 protein, human
    Language English
    Publishing date 2008-06-03
    Publishing country United States
    Document type Comment ; Editorial
    ZDB-ID 605507-2
    ISSN 1558-3597 ; 0735-1097
    ISSN (online) 1558-3597
    ISSN 0735-1097
    DOI 10.1016/j.jacc.2008.02.060
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Multiple Cardiac Biomarker Testing Among Patients With Acute Dyspnea From the ICON-RELOADED Study.

    Abboud, Andrew / Kui, Naishu / Gaggin, Hanna K / Ibrahim, Nasrien E / Chen-Tournoux, Annabel A / Christenson, Robert H / Hollander, Judd E / Levy, Phillip D / Nagurney, John T / Nowak, Richard M / Pang, Peter S / Peacock, W Franklin / Walters, Elizabeth L / Januzzi, James L

    Journal of cardiac failure

    2021  Volume 28, Issue 2, Page(s) 226–233

    Abstract: Background: Among patients with acute dyspnea, concentrations of N-terminal pro-B-type natriuretic peptide (NT-proBNP), high-sensitivity cardiac troponin T, and insulin-like growth factor binding protein-7 predict cardiovascular outcomes and death. ... ...

    Abstract Background: Among patients with acute dyspnea, concentrations of N-terminal pro-B-type natriuretic peptide (NT-proBNP), high-sensitivity cardiac troponin T, and insulin-like growth factor binding protein-7 predict cardiovascular outcomes and death. Understanding the optimal means to interpret these elevated biomarkers in patients presenting with acute dyspnea remains unknown.
    Methods and results: Concentrations of NT-proBNP, high-sensitivity cardiac troponin T, and insulin-like growth factor binding protein-7 were analyzed in 1448 patients presenting with acute dyspnea from the prospective, multicenter International Collaborative of NT-proBNP-Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department (ICON-RELOADED) Study. Eight biogroups were derived based upon patterns in biomarker elevation at presentation and compared for differences in baseline characteristics. Of 441 patients with elevations in all 3 biomarkers, 218 (49.4%) were diagnosed with acute heart failure (HF). The frequency of acute HF diagnosis in this biogroup was higher than those with elevations in 2 biomarkers (18.8%, 44 of 234), 1 biomarker (3.8%, 10 of 260), or no elevated biomarkers (0.4%, 2 of 513). The absolute number of elevated biomarkers on admission was prognostic of the composite end point of mortality and HF rehospitalization. In adjusted models, patients with one, 2, and 3 elevated biomarkers had 3.74 (95% confidence interval [CI], 1.26-11.1, P = .017), 12.3 (95% CI, 4.60-32.9, P < .001), and 12.6 (95% CI, 4.54-35.0, P < .001) fold increased risk of 180-day mortality or HF rehospitalization.
    Conclusions: A multimarker panel of NT-proBNP, hsTnT, and IGBFP7 provides unique clinical, diagnostic, and prognostic information in patients presenting with acute dyspnea. Differences in the number of elevated biomarkers at presentation may allow for more efficient clinical risk stratification of short-term mortality and HF rehospitalization.
    MeSH term(s) Biomarkers ; Dyspnea/diagnosis ; Dyspnea/epidemiology ; Dyspnea/etiology ; Heart Failure/complications ; Heart Failure/diagnosis ; Humans ; Natriuretic Peptide, Brain ; Peptide Fragments ; Prognosis ; Prospective Studies
    Chemical Substances Biomarkers ; Peptide Fragments ; Natriuretic Peptide, Brain (114471-18-0)
    Language English
    Publishing date 2021-10-09
    Publishing country United States
    Document type Journal Article ; Multicenter Study
    ZDB-ID 1281194-4
    ISSN 1532-8414 ; 1071-9164
    ISSN (online) 1532-8414
    ISSN 1071-9164
    DOI 10.1016/j.cardfail.2021.08.025
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Emergency department management of patients with acute decompensated heart failure.

    Peacock, W Franklin / Emerman, Charles L

    Heart failure reviews

    2004  Volume 9, Issue 3, Page(s) 187–193

    Abstract: The Acute Decompensated HEart Failure National REgistry (ADHERE(R)) confirms that the management of decompensated heart failure is an emergency department (ED) problem, as more than 75% of patients admitted to the hospital with heart failure arrive ... ...

    Abstract The Acute Decompensated HEart Failure National REgistry (ADHERE(R)) confirms that the management of decompensated heart failure is an emergency department (ED) problem, as more than 75% of patients admitted to the hospital with heart failure arrive through the ED. This emphasizes the need for collaboration among emergency medicine, cardiology, nephrology, and hospitalists in the management of acute decompensated heart failure. Such collaboration is important for several reasons, including the enhancement of patient care. It is also known that most hospitals lose money on heart failure admissions. Strategies that can be employed to limit hospital losses on heart failure include reducing admissions from the ED; decreasing the length of hospital stay; increasing the use of the observation unit; reducing re-admissions, particularly through the first 30 days; and reducing the use of high-resource areas such as the intensive care unit (ICU). This article will focus on initiatives that can be implemented in the ED to help with these strategies. In particular, we will discuss early initiation of therapy and its ability to improve length of stay, reduce re-admissions, and reduce ICU admissions. Use of the observation unit for the management of heart failure will also be discussed as a way of decreasing admissions from the ED.
    MeSH term(s) Acute Disease ; Diuretics/therapeutic use ; Emergency Service, Hospital/economics ; Health Care Costs ; Heart Failure/diagnosis ; Heart Failure/economics ; Heart Failure/therapy ; Humans ; Patient Admission/economics ; Vasoconstrictor Agents/therapeutic use
    Chemical Substances Diuretics ; Vasoconstrictor Agents
    Language English
    Publishing date 2004-07
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1336499-6
    ISSN 1573-7322 ; 1382-4147
    ISSN (online) 1573-7322
    ISSN 1382-4147
    DOI 10.1007/s10741-005-6128-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Assessing clinical risk prediction tools.

    Fonarow, Gregg C / Diercks, Deborah B / Peacock, W Franklin

    Annals of emergency medicine

    2007  Volume 50, Issue 6, Page(s) 741–2; author reply 742

    MeSH term(s) Decision Support Techniques ; Emergency Medicine/methods ; Heart Failure/diagnosis ; Heart Failure/mortality ; Heart Failure/therapy ; Humans ; Outcome and Process Assessment (Health Care)/methods ; Risk Assessment
    Language English
    Publishing date 2007-12
    Publishing country United States
    Document type Comment ; Letter
    ZDB-ID 603080-4
    ISSN 1097-6760 ; 0196-0644
    ISSN (online) 1097-6760
    ISSN 0196-0644
    DOI 10.1016/j.annemergmed.2007.05.028
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Optimizing treatment and outcomes in acute heart failure: beyond initial triage.

    Silver, Marc A / Peacock, W Franklin / Diercks, Deborah B

    Congestive heart failure (Greenwich, Conn.)

    2006  Volume 12, Issue 3, Page(s) 137–145

    Abstract: Heart failure contributes substantially to health care costs in the United States due to its prevalence and frequent necessity for repeat hospitalizations to manage episodes of acute decompensation. Heart failure overwhelmingly impacts Medicare costs, as ...

    Abstract Heart failure contributes substantially to health care costs in the United States due to its prevalence and frequent necessity for repeat hospitalizations to manage episodes of acute decompensation. Heart failure overwhelmingly impacts Medicare costs, as the highest proportion of heart failure patients are older than 65 years of age. Efforts to reduce morbidity, mortality, and health care resource utilization have been achieved successfully through emergency department-based heart failure observation units. For select patients, the observation unit can provide care with effective oral agents, including angiotensin-converting enzyme inhibitors, beta-adrenergic receptor blockers, and diuretics, as well as administration of other vasoactive agents, followed by a discharge plan of effective heart failure education and rigorous follow-up management. As advanced pharmacologic and diagnostic therapies continue to emerge, the observation unit staff can play an integral role in the critical education and self-management tools that are needed by the patient to ultimately improve outcomes and quality of life.
    MeSH term(s) Acute Disease ; Algorithms ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Diuretics/therapeutic use ; Emergency Service, Hospital/organization & administration ; Heart Failure/diagnosis ; Heart Failure/drug therapy ; Hospital Units/statistics & numerical data ; Humans ; Observation ; Patient Admission ; Treatment Outcome ; Triage ; Vasodilator Agents/therapeutic use
    Chemical Substances Angiotensin-Converting Enzyme Inhibitors ; Diuretics ; Vasodilator Agents
    Language English
    Publishing date 2006-05-25
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1239105-0
    ISSN 1751-7133 ; 1527-5299 ; 1079-7998
    ISSN (online) 1751-7133
    ISSN 1527-5299 ; 1079-7998
    DOI 10.1111/j.1527-5299.2006.05413.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Nesiritide added to standard care favorably reduces systolic blood pressure compared with standard care alone in patients with acute decompensated heart failure.

    Peacock, W Franklin / Emerman, Charles L / Silver, Marc A

    The American journal of emergency medicine

    2005  Volume 23, Issue 3, Page(s) 327–331

    Abstract: The Prospective Randomized Outcomes study of Acutely decompensated Congestive heart failure Treated Initially as Outpatients with Nesiritide (PROACTION) trial evaluated the safety of nesiritide administration in the emergency department in patients with ... ...

    Abstract The Prospective Randomized Outcomes study of Acutely decompensated Congestive heart failure Treated Initially as Outpatients with Nesiritide (PROACTION) trial evaluated the safety of nesiritide administration in the emergency department in patients with decompensated heart failure. Patients (N=237) were treated for at least 12 hours with standard care plus either intravenous nesiritide or placebo. Compared to placebo, nesiritide favorably decreased systolic blood pressure (SBP) in patients with elevated baseline SBP, without negatively impacting patients with lower baseline SBP (SBP, >140 mm Hg: nesiritide, -28.7 mm Hg, vs placebo, -8.4 mm Hg [P<.001]; SBP, 101-140 mm Hg: nesiritide, -12.3 mm Hg, vs placebo, -5 mm Hg [P<.017]; SBP, <101 mm Hg: nesiritide, -1.2 mm Hg vs placebo, +16.7 mm Hg [P<.03]). Both treatment groups had similar incidences of symptomatic and asymptomatic hypotension. These data demonstrate that early administration of nesiritide in the emergency department is a safe and effective treatment of heart failure.
    MeSH term(s) Aged ; Blood Pressure/drug effects ; Double-Blind Method ; Emergency Service, Hospital ; Female ; Heart Failure/classification ; Heart Failure/drug therapy ; Heart Failure/therapy ; Humans ; Hypotension/chemically induced ; Male ; Natriuretic Agents/therapeutic use ; Natriuretic Peptide, Brain/adverse effects ; Natriuretic Peptide, Brain/therapeutic use
    Chemical Substances Natriuretic Agents ; Natriuretic Peptide, Brain (114471-18-0)
    Language English
    Publishing date 2005-05-01
    Publishing country United States
    Document type Clinical Trial ; Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 605890-5
    ISSN 0735-6757
    ISSN 0735-6757
    DOI 10.1016/j.ajem.2004.11.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study.

    Januzzi, James L / Chen-Tournoux, Annabel A / Christenson, Robert H / Doros, Gheorghe / Hollander, Judd E / Levy, Phillip D / Nagurney, John T / Nowak, Richard M / Pang, Peter S / Patel, Darshita / Peacock, W Franklin / Rivers, E Joy / Walters, Elizabeth L / Gaggin, Hanna K

    Journal of the American College of Cardiology

    2018  Volume 71, Issue 11, Page(s) 1191–1200

    Abstract: Background: Contemporary reconsideration of diagnostic N-terminal pro-B-type natriuretic peptide (NT-proBNP) cutoffs for diagnosis of heart failure (HF) is needed.: Objectives: This study sought to evaluate the diagnostic performance of NT-proBNP for ...

    Abstract Background: Contemporary reconsideration of diagnostic N-terminal pro-B-type natriuretic peptide (NT-proBNP) cutoffs for diagnosis of heart failure (HF) is needed.
    Objectives: This study sought to evaluate the diagnostic performance of NT-proBNP for acute HF in patients with dyspnea in the emergency department (ED) setting.
    Methods: Dyspneic patients presenting to 19 EDs in North America were enrolled and had blood drawn for subsequent NT-proBNP measurement. Primary endpoints were positive predictive values of age-stratified cutoffs (450, 900, and 1,800 pg/ml) for diagnosis of acute HF and negative predictive value of the rule-out cutoff to exclude acute HF. Secondary endpoints included sensitivity, specificity, and positive (+) and negative (-) likelihood ratios (LRs) for acute HF.
    Results: Of 1,461 subjects, 277 (19%) were adjudicated as having acute HF. The area under the receiver-operating characteristic curve for diagnosis of acute HF was 0.91 (95% confidence interval [CI]: 0.90 to 0.93; p < 0.001). Sensitivity for age stratified cutoffs of 450, 900, and 1,800 pg/ml was 85.7%, 79.3%, and 75.9%, respectively; specificity was 93.9%, 84.0%, and 75.0%, respectively. Positive predictive values were 53.6%, 58.4%, and 62.0%, respectively. Overall LR+ across age-dependent cutoffs was 5.99 (95% CI: 5.05 to 6.93); individual LR+ for age-dependent cutoffs was 14.08, 4.95, and 3.03, respectively. The sensitivity and negative predictive value for the rule-out cutoff of 300 pg/ml were 93.9% and 98.0%, respectively; LR- was 0.09 (95% CI: 0.05 to 0.13).
    Conclusions: In acutely dyspneic patients seen in the ED setting, age-stratified NT-proBNP cutpoints may aid in the diagnosis of acute HF. An NT-proBNP <300 pg/ml strongly excludes the presence of acute HF.
    MeSH term(s) Age Factors ; Aged ; Biomarkers/blood ; Dyspnea/blood ; Dyspnea/etiology ; Emergency Service, Hospital ; Female ; Heart Failure/blood ; Heart Failure/complications ; Heart Failure/diagnosis ; Humans ; Male ; Middle Aged ; Natriuretic Peptide, Brain/blood ; Peptide Fragments/blood ; Predictive Value of Tests ; Prognosis ; Prospective Studies ; Reproducibility of Results ; Risk Assessment
    Chemical Substances Biomarkers ; Peptide Fragments ; pro-brain natriuretic peptide (1-76) ; Natriuretic Peptide, Brain (114471-18-0)
    Language English
    Publishing date 2018-03-15
    Publishing country United States
    Document type Clinical Trial ; Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 605507-2
    ISSN 1558-3597 ; 0735-1097
    ISSN (online) 1558-3597
    ISSN 0735-1097
    DOI 10.1016/j.jacc.2018.01.021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: ED patients with heart failure: identification of an observational unit-appropriate cohort.

    Diercks, Deborah B / Peacock, W Franklin / Kirk, J Douglas / Weber, Jim E

    The American journal of emergency medicine

    2006  Volume 24, Issue 3, Page(s) 319–324

    Abstract: Objective: To identify factors that define a low-risk cohort of patients with acute decompensated heart failure who are suitable for management in an observation unit.: Methods: Prospective convenience sample of 538 patients who presented to an ED ... ...

    Abstract Objective: To identify factors that define a low-risk cohort of patients with acute decompensated heart failure who are suitable for management in an observation unit.
    Methods: Prospective convenience sample of 538 patients who presented to an ED with a diagnosis of congestive heart failure. Observation unit appropriate was defined as a length of stay less than 24 hours and no adverse events (myocardial infarction, death, arrhythmia, or rehospitalization) during the 30-day follow-up period.
    Results: Study criteria were met by 499 patients (mean age, 61 +/- 15 years), and 234 (47%) were women. Of these, 133 (27%) met the criteria for observation unit appropriateness. Independent predictors were systolic blood pressure of greater than 160 (odds ratio, 1.8; 95% confidence interval, 1.15-2.7) and normal troponin I (odds ratio, 14.7; 95% confidence interval, 1.9-105).
    Conclusion: Initial blood pressure and troponin I can help identify patients with congestive heart failure at low risk for prolonged hospitalization and adverse events and who are reasonable candidates for observation unit management.
    MeSH term(s) Aged ; Blood Pressure Determination ; Chi-Square Distribution ; Emergency Service, Hospital/organization & administration ; Female ; Heart Failure/blood ; Hospital Units/organization & administration ; Hospitalization/statistics & numerical data ; Humans ; Length of Stay/statistics & numerical data ; Male ; Middle Aged ; Observation ; Outcome Assessment (Health Care) ; Patient Selection ; Prospective Studies ; Troponin I/blood
    Chemical Substances Troponin I
    Language English
    Publishing date 2006-05
    Publishing country United States
    Document type Journal Article
    ZDB-ID 605890-5
    ISSN 0735-6757
    ISSN 0735-6757
    DOI 10.1016/j.ajem.2005.11.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Current and emerging issues with B-type natriuretic peptide. Roundtable discussion.

    Silver, Marc A / Rosendorff, Clive / Berkowitz, Robert / Peacock, W Franklin

    Congestive heart failure (Greenwich, Conn.)

    2005  Volume 11, Issue 4, Page(s) 212–214

    Abstract: A brief panel discussion was held on March 23, 2005, in New York City following a live symposium for primary care physicians discussing the roles of B-type natriuretic peptide in a variety of cardiovascular diseases. The participants were Dr. Marc A. ... ...

    Abstract A brief panel discussion was held on March 23, 2005, in New York City following a live symposium for primary care physicians discussing the roles of B-type natriuretic peptide in a variety of cardiovascular diseases. The participants were Dr. Marc A. Silver, Advocate Christ Medical Center, Oak Lawn, IL; Dr. Clive Rosendorff, Mount Sinai School of Medicine, New York, NY and VA Medical Center, Bronx, NY; Dr. Robert Berkowitz, Hackensack University Medical Center, Hackensack, NJ; and Dr. W. Franklin Peacock IV, The Cleveland Clinic Department of Emergency Medicine, Cleveland, OH. Dr. Silver moderated the discussion. The panel gathered to review some of the questions that emerged from the symposium and the questions raised by the attendees. These are of interest and importance to all interested in heart failure and B-type natriuretic peptide.
    MeSH term(s) Heart Failure/diagnosis ; Heart Failure/physiopathology ; Humans ; Natriuretic Peptide, Brain/analysis ; Prognosis ; Risk Assessment
    Chemical Substances Natriuretic Peptide, Brain (114471-18-0)
    Language English
    Publishing date 2005-08-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1239105-0
    ISSN 1751-7133 ; 1527-5299 ; 1079-7998
    ISSN (online) 1751-7133
    ISSN 1527-5299 ; 1079-7998
    DOI 10.1111/j.1527-5299.2005.04570.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top